Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma

被引：0
|
作者：
Yorgancioglu, A. A. [1 ]
Pavord, I. [2 ]
Brusselle, G. [3 ]
Pitrez, P. [4 ]
Oosterholt, S. [5 ]
Pg, A. [6 ]
Della Pasqua, O. [7 ]
机构：
[1] Celal Bayar Univ, Manisa, Turkey
[2] Univ Oxford, Nuffield Dept Med, Oxford, England
[3] Univ Ghent, Ghent, Belgium
[4] Hosp Santa Casa Porto Alegre, Porto Alegre, RS, Brazil
[5] GlaxoSmithKline, Clin Pharmacol Modelling & Simulat, London, England
[6] GlaxoSmithKline, Global Class & Established Med, Singapore, Singapore
[7] UCL, Clin Pharmacol & Therapeut Grp, London, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
基金：
芬兰科学院;
关键词：
D O I：
10.1183/13993003.congress-2022.4572
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
4572
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Understanding the Clinical Implications of Individual Patient Characteristics and Treatment Choice on the Risk of Exacerbation in Asthma Patients with Moderate-Severe Symptoms
    Singh, Dave
    Oosterholt, Sean
    Pavord, Ian
    Garcia, Gabriel
    Abhijith, P. G.
    Della Pasqua, Oscar
    [J]. ADVANCES IN THERAPY, 2023, 40 (10) : 4606 - 4625
  • [2] SEVERE ASTHMA TREATABLE TRAITS: PREVALENCE AND EXACERBATION PREDICTION
    Mcdonald, V
    Godbout, K.
    Hiles, S.
    Harvey, E.
    Gibson, P.
    [J]. RESPIROLOGY, 2018, 23 : 69 - 69
  • [3] USEFULNESS OF THEOPHYLLINE IN THE TREATMENT OF MODERATE-SEVERE ASTHMA
    RIVAS, PC
    ROCHA, RG
    FERNANDEZ, EB
    SANZ, CC
    GRACIA, FD
    [J]. REVISTA CLINICA ESPANOLA, 1994, 194 (04): : 288 - 290
  • [4] Identification of treatable traits in a severe asthma registry: prevalence and exacerbation predictors
    McDonald, Vanessa M.
    Hiles, Sarah A.
    Godbout, Krystelle
    Harvey, Erin S.
    Marks, Guy B.
    Hew, Mark
    Peters, Matthew
    Bardin, Philip
    Reynolds, Paul N.
    Upham, John W.
    Baraket, Melissa
    Bhikoo, Zaheerodin
    Bowden, Jeffrey
    Brockway, Ben
    Chung, Li Ping
    Cochrane, Belinda
    Foxley, Gloria
    Garrett, Jeffrey
    Jayaram, Lata
    Jenkins, Christine
    Katelaris, Constance
    Katsoulotos, Gregory
    Koh, Mariko S.
    Kritikos, Vicky
    Lambert, Marina
    Langton, David
    Rivero, Alexis Lara
    Middleton, Peter
    Nanguzgambo, Aldoph
    Radhakrishna, Naghmeh
    Reddel, Helen
    Rimmer, Janet
    Southcott, Anne Marie
    Sutherland, Michael
    Thien, Francis
    Wark, Peter
    Yang, Ian A.
    Yap, Elaine
    Gibson, Peter G.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [5] Asthma exacerbation prevalence during the covid-19 lockdown in a moderate-severe asthma cohort
    De Boer, G.
    Braunstahl, G.
    Hendriks, R.
    Tramper, G.
    [J]. ALLERGY, 2021, 76 : 106 - 106
  • [6] Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort
    de Boer, Geertje
    Braunstahl, Gert-Jan
    Hendriks, Rudi
    Tramper-Stranders, Gerdien
    [J]. BMJ OPEN RESPIRATORY RESEARCH, 2021, 8 (01)
  • [7] A Simulation Study of the Effect of Clinical Characteristics and Treatment Choice on Reliever Medication Use, Symptom Control and Exacerbation Risk in Moderate-Severe Asthma
    Garcia, Gabriel
    van Dijkman, Sven C.
    Pavord, Ian
    Singh, Dave
    Oosterholt, Sean
    Fulmali, Sourabh
    Majumdar, Anurita
    Della Pasqua, Oscar
    [J]. ADVANCES IN THERAPY, 2024, 41 (08) : 3196 - 3216
  • [8] The dilemma of reducing treatment for patients with moderate-severe controlled asthma
    Marin Romero, S.
    Jara Palomares, L.
    [J]. REVISTA CLINICA ESPANOLA, 2020, 220 (02): : 117 - 118
  • [9] Sex and Treatable Traits in Severe Asthma
    Park, Han-Ki
    Song, Woo-Jung
    [J]. ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2021, 13 (02) : 167 - 170
  • [10] TREATABLE TRAITS IN A SEVERE ASTHMA COHORT
    Connolly, C.
    Borg, C.
    Gittins, A.
    Shrimanker, R.
    Hynes, G.
    Hinks, T.
    Pavord, I.
    [J]. THORAX, 2018, 73 : A123 - A124
12345